ESR1 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC) is widely known as the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) expressions, which makes it a lack of targets for precise and effective treatment [1,2].